Trial Outcomes & Findings for Improving Hypertension Medication Adherence for Older Adults (NCT NCT05610059)

NCT ID: NCT05610059

Last Updated: 2026-07-31

Results Overview

The Medication Event Monitoring System (MEMS®Cap) assesses objective medication adherence using the smart pill bottle cap. Digital sensors in the track cap automatically record the date and time of cap opening and upload the information to AARDEX Medication Adherence Software. Percentage of medication taken at the correct time frame.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

200 participants

Primary outcome timeframe

3 months, 6 months

Results posted on

2026-07-31

Participant Flow

Additional Information: The difference between the number of participants enrolled in the study and the number who started the study is because only those with hypertension medication adherence of 90% or less started the study. Data Element Definition: A 28-day adherence monitoring period after enrollment determined adherence (90% or less to receive intervention) before participant randomization.

Participant milestones

Participant milestones
Measure
Blood Pressure Technology System M
These participants received information about high blood pressure, medications, and strategies that can be used to remember to take medications for managing blood pressure. They completed a mid-assessment at 3-months and a post-assessment at 6-months.
Blood Pressure Technology System E
These participants received information about high blood pressure and medications. They completed a mid-assessment at 3-months and a post-assessment at 6-months.
Enrolled But Not Randomized/Treated
These participants completed the baseline data collection but were excluded after the 28-day adherence monitoring period, after which they had hypertension medication adherence greater than 90%.
Overall Study
STARTED
34
32
134
Overall Study
COMPLETED
27
30
0
Overall Study
NOT COMPLETED
7
2
134

Reasons for withdrawal

Reasons for withdrawal
Measure
Blood Pressure Technology System M
These participants received information about high blood pressure, medications, and strategies that can be used to remember to take medications for managing blood pressure. They completed a mid-assessment at 3-months and a post-assessment at 6-months.
Blood Pressure Technology System E
These participants received information about high blood pressure and medications. They completed a mid-assessment at 3-months and a post-assessment at 6-months.
Enrolled But Not Randomized/Treated
These participants completed the baseline data collection but were excluded after the 28-day adherence monitoring period, after which they had hypertension medication adherence greater than 90%.
Overall Study
Adherence >90% after 28-day monitoring period
0
0
134
Overall Study
Lost to Follow-up
7
2
0

Baseline Characteristics

Improving Hypertension Medication Adherence for Older Adults

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Blood Pressure Technology System M
n=34 Participants
These participants will receive information about high blood pressure, medications and strategies that can be used to take medications and manage blood pressure. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
Blood Pressure Technology System E
n=32 Participants
These participants receive information about high blood pressure and medications. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
Enrolled But Not Randomized/Treated
n=134 Participants
Participants completed the baseline data collection but were excluded after the 28-day adherence monitoring period after which they had hypertension medication adherence greater than 90%. Other reasons for exclusion included having no time, no longer interested, share same household as another participant, did not want to change medication strategy, and scheduling conflict.
Total
n=200 Participants
Total of all reporting groups
Age, Continuous
75.26 years
STANDARD_DEVIATION 6.65 • n=9 Participants
74.00 years
STANDARD_DEVIATION 7.44 • n=27 Participants
74.16 years
STANDARD_DEVIATION 6.04 • n=267 Participants
74.65 years
STANDARD_DEVIATION 7.02 • n=265 Participants
Sex: Female, Male
Female
23 Participants
n=9 Participants
27 Participants
n=27 Participants
76 Participants
n=267 Participants
126 Participants
n=265 Participants
Sex: Female, Male
Male
11 Participants
n=9 Participants
5 Participants
n=27 Participants
58 Participants
n=267 Participants
74 Participants
n=265 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
n=9 Participants
0 Participants
n=27 Participants
1 Participants
n=267 Participants
2 Participants
n=265 Participants
Race (NIH/OMB)
Asian
3 Participants
n=9 Participants
0 Participants
n=27 Participants
4 Participants
n=267 Participants
7 Participants
n=265 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=9 Participants
0 Participants
n=27 Participants
1 Participants
n=267 Participants
1 Participants
n=265 Participants
Race (NIH/OMB)
Black or African American
2 Participants
n=9 Participants
2 Participants
n=27 Participants
1 Participants
n=267 Participants
5 Participants
n=265 Participants
Race (NIH/OMB)
White
27 Participants
n=9 Participants
28 Participants
n=27 Participants
124 Participants
n=267 Participants
179 Participants
n=265 Participants
Race (NIH/OMB)
More than one race
1 Participants
n=9 Participants
0 Participants
n=27 Participants
1 Participants
n=267 Participants
2 Participants
n=265 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=9 Participants
2 Participants
n=27 Participants
2 Participants
n=267 Participants
4 Participants
n=265 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants
n=9 Participants
1 Participants
n=27 Participants
2 Participants
n=267 Participants
5 Participants
n=265 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
32 Participants
n=9 Participants
31 Participants
n=27 Participants
132 Participants
n=267 Participants
195 Participants
n=265 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=9 Participants
0 Participants
n=27 Participants
0 Participants
n=267 Participants
0 Participants
n=265 Participants
Region of Enrollment
United States
34 Participants
n=9 Participants
32 Participants
n=27 Participants
134 Participants
n=267 Participants
200 Participants
n=265 Participants
Medication adherence (MEMS Cap)
62.76 Percentage
STANDARD_DEVIATION 28.32 • n=9 Participants
70.72 Percentage
STANDARD_DEVIATION 22.20 • n=27 Participants
96.40 Percentage
STANDARD_DEVIATION 3.23 • n=267 Participants
66.62 Percentage
STANDARD_DEVIATION 25.66 • n=265 Participants
Medication Adherence Report Scale (MARS-5)
24.03 Score on a scale
STANDARD_DEVIATION 1.17 • n=9 Participants
23.69 Score on a scale
STANDARD_DEVIATION 1.38 • n=27 Participants
24.26 Score on a scale
STANDARD_DEVIATION 1.28 • n=267 Participants
23.86 Score on a scale
STANDARD_DEVIATION 1.28 • n=265 Participants

PRIMARY outcome

Timeframe: 3 months, 6 months

The Medication Event Monitoring System (MEMS®Cap) assesses objective medication adherence using the smart pill bottle cap. Digital sensors in the track cap automatically record the date and time of cap opening and upload the information to AARDEX Medication Adherence Software. Percentage of medication taken at the correct time frame.

Outcome measures

Outcome measures
Measure
Blood Pressure Technology System M
n=34 Participants
These participants will receive information about high blood pressure, medications and strategies that can be used to take medications and manage blood pressure. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
Blood Pressure Technology System E
n=32 Participants
These participants receive information about high blood pressure and medications. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
Medication Adherence (MEMS Cap)
3 months
67.29 Percentage
Standard Deviation 0.31
53.72 Percentage
Standard Deviation 0.32
Medication Adherence (MEMS Cap)
6 months
63.47 Percentage
Standard Deviation 0.32
53.56 Percentage
Standard Deviation 0.36

PRIMARY outcome

Timeframe: 3 months, 6 months

The Medication Adherence Report Scale (MARS-5) is a 5-item self-report scale to assess medication adherence related to the frequency of not taking a prescribed dose of medication or not taking the dose prescribed. Self-report score of 5-25. Item scores are summed for a total scale score, where higher scores reflect greater medication adherence. Scale: 5=never, 4=rarely, 3=sometimes, 2=often, and 1=always.

Outcome measures

Outcome measures
Measure
Blood Pressure Technology System M
n=34 Participants
These participants will receive information about high blood pressure, medications and strategies that can be used to take medications and manage blood pressure. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
Blood Pressure Technology System E
n=32 Participants
These participants receive information about high blood pressure and medications. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
Medication Adherence Report Scale (MARS-5)
3 months
23.62 Score on a scale
Standard Deviation 1.83
24.00 Score on a scale
Standard Deviation 1.48
Medication Adherence Report Scale (MARS-5)
6 months
23.94 Score on a scale
Standard Deviation 1.48
23.66 Score on a scale
Standard Deviation 1.68

SECONDARY outcome

Timeframe: Baseline, 3-months, 6-months

The mean of two seated blood pressure readings taken at least 15 minutes apart using a validated automated device. 6-month change in mean seated systolic BP among M system users versus E system users.

Outcome measures

Outcome measures
Measure
Blood Pressure Technology System M
n=34 Participants
These participants will receive information about high blood pressure, medications and strategies that can be used to take medications and manage blood pressure. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
Blood Pressure Technology System E
n=32 Participants
These participants receive information about high blood pressure and medications. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
Systolic Blood Pressure (SBP)
Baseline
131.93 mm Hg
Standard Deviation 17.93
133.44 mm Hg
Standard Deviation 20.06
Systolic Blood Pressure (SBP)
3 months
133.29 mm Hg
Standard Deviation 15.27
129.34 mm Hg
Standard Deviation 17.13
Systolic Blood Pressure (SBP)
6 months
134.63 mm Hg
Standard Deviation 18.65
130.59 mm Hg
Standard Deviation 21.04

SECONDARY outcome

Timeframe: Baseline, 3-months, 6-months

The Treatment Self-Regulation Questionnaire (TSRQ) assesses perceived autonomy, treatment-related motivation, and health behavior change. A 15-item questionnaire measures motivation and regulation styles that individuals employ to manage their health-related treatments or behaviors. Scale: 1=Not at all true to 7=Very true. Score 1-7 for each of the following components: TSRQ Autonomous motivation, TSRQ Introjected regulation, TSRQ External regulation, and TSRQ Amotivation. The subscales are averaged to report the mean TSRQ score. Higher numbers indicate higher autonomous motivation, controlled motivation, or amotivation. 6-month change in perceived autonomy among M system users versus E system users.

Outcome measures

Outcome measures
Measure
Blood Pressure Technology System M
n=34 Participants
These participants will receive information about high blood pressure, medications and strategies that can be used to take medications and manage blood pressure. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
Blood Pressure Technology System E
n=32 Participants
These participants receive information about high blood pressure and medications. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
Perceived Autonomy
Baseline
6.66 Score on a scale
Standard Deviation 0.50
6.65 Score on a scale
Standard Deviation 0.49
Perceived Autonomy
3 months
6.80 Score on a scale
Standard Deviation 0.38
6.66 Score on a scale
Standard Deviation 0.49
Perceived Autonomy
6 months
6.84 Score on a scale
Standard Deviation 0.35
6.76 Score on a scale
Standard Deviation 0.49

SECONDARY outcome

Timeframe: Baseline, 3-months, 6-months

The Perceived Competence Scale (PCS) is a 4-item questionnaire designed to measure self-perceptions of competence in different contexts (e.g., managing medications). We modified the questions to reflect blood pressure medications. Scale: 1=Not at all true to 7=Very true. Each score on the scale is summed, and a total score is reported (ranges between 4 and 28), with higher scores indicating higher perceived competence with medication adherence. 6-month change in perceived competence among M system users versus E system users.

Outcome measures

Outcome measures
Measure
Blood Pressure Technology System M
n=34 Participants
These participants will receive information about high blood pressure, medications and strategies that can be used to take medications and manage blood pressure. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
Blood Pressure Technology System E
n=32 Participants
These participants receive information about high blood pressure and medications. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
Perceived Competence
Baseline
24.88 Score on a scale
Standard Deviation 4.99
25.94 Score on a scale
Standard Deviation 3.60
Perceived Competence
3 months
25.00 Score on a scale
Standard Deviation 4.90
25.59 Score on a scale
Standard Deviation 3.56
Perceived Competence
6 months
25.29 Score on a scale
Standard Deviation 4.86
26.16 Score on a scale
Standard Deviation 3.33

SECONDARY outcome

Timeframe: Baseline, 3-months, 6-months

The Mobile Device Proficiency Questionnaire (MDPQ) assesses experience with mobile devices, comfort level, and successful use. A 16-item survey measures older adults' proficiency and comfort level in using mobile devices such as smartphones and tablets, including navigating various features and functions. Each questionnaire item is assigned a value from 1 to 5 (1 = Never Tried; 5 = Very Easily). Eight subscale scores are computed by taking the mean of the items within each respective subscale. The overall score is calculated by adding together all subscale scores. The MDPQ-16 total score ranges from 8 to 40, with higher scores reflecting greater proficiency. 6-month change in mobile device proficiency among M system users versus E system users.

Outcome measures

Outcome measures
Measure
Blood Pressure Technology System M
n=34 Participants
These participants will receive information about high blood pressure, medications and strategies that can be used to take medications and manage blood pressure. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
Blood Pressure Technology System E
n=32 Participants
These participants receive information about high blood pressure and medications. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
Mobile Device Proficiency
6 months
33.21 Score on a scale
Standard Deviation 6.89
34.41 Score on a scale
Standard Deviation 5.21
Mobile Device Proficiency
Baseline
32.93 Score on a scale
Standard Deviation 6.62
33.88 Score on a scale
Standard Deviation 5.73
Mobile Device Proficiency
3 months
33.26 Score on a scale
Standard Deviation 6.00
34.58 Score on a scale
Standard Deviation 4.58

SECONDARY outcome

Timeframe: Baseline, 6 months

The Hypertension Knowledge Level Scale (HK-LS) consists of 22 questions with 6 sub-dimensions and scores, including: HK-LS Definition \[0-2\], HK-LS Medical treatment \[0-4\], HK-LS Drug Compliance \[0-4\], HK-LS Lifestyle \[0-5\], HK-LS Diet \[0-2\], and HK-LS Complications \[0-5\]. The sub-dimension scores are summed to generate an overall score. The HK-LS Overall ranges from 0 to 22, with a higher score indicating higher knowledge about hypertension.

Outcome measures

Outcome measures
Measure
Blood Pressure Technology System M
n=34 Participants
These participants will receive information about high blood pressure, medications and strategies that can be used to take medications and manage blood pressure. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
Blood Pressure Technology System E
n=32 Participants
These participants receive information about high blood pressure and medications. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
Hypertension Knowledge Level Scale
Baseline
18.02 Score on a scale
Standard Deviation 2.72
17.97 Score on a scale
Standard Deviation 2.52
Hypertension Knowledge Level Scale
6 months
18.62 Score on a scale
Standard Deviation 2.57
18.59 Score on a scale
Standard Deviation 3.17

Adverse Events

Blood Pressure Technology System M

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Blood Pressure Technology System E

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Enrolled But Not Randomized/Treated

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Jeannie Lee

The University of Arizona

Phone: 5206269419

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place